The antidiuretic effect of pneumadin requires a functional arginine vasopressin system

John D. Watson, Donald B. Jennings, Inder R. Sarda, Stephen C. Pang, Barbara Lawson, Dennis A Wigle, T. Geoffrey Flynn

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Pneumadin is an antidiuretic decapeptide, recently isolated from rat and human lung. Bolus intravenous injection of 5 nmol of pneumadin into water-loaded rats caused a rapid and significant antidiuresis and a reduction in Na+ and Cl- excretion. Pneumadin administration did not alter mean arterial pressure, right atrial pressure, heart rate or haematocrit. Bolus intravenous injection of 20 nmol of pneumadin into non-water-loaded rats caused a significant increase in arginine vasopressin (AVP) within 10 min. Pneumadin administration also increased circulating atrial natriuretic peptide (ANP) but did not alter aldosterone or plasma renin activity levels. Injection of pneumadin into water-loaded Brattleboro rats, which genetically lack circulating AVP, did not change urine flow, confirming that the pneumadin induced antidiuresis is AVP dependent. Radioactive pneumadin was cleared from the circulation with a t 1 2β of 480.3 s. Radioactive pneumadin, isolated from plasma, eluted at an altered position on reverse phase HPLC, which indicated that the peptide was modified in vivo. This modification was also observed when synthetic pneumadin was incubated in rat plasma in vitro. Purification and sequencing of the modified synthetic peptide indicated that the modification is not a proteolytic cleavage. These results indicate that pneumadin injected into the rat caused an antidiuresis by altering circulating AVP levels.

Original languageEnglish (US)
Pages (from-to)105-114
Number of pages10
JournalRegulatory Peptides
Volume57
Issue number2
DOIs
StatePublished - May 30 1995
Externally publishedYes

Fingerprint

Antidiuretic Agents
Arginine Vasopressin
Rats
Plasmas
Intravenous Injections
pneumadin
Brattleboro Rats
Peptides
Atrial Pressure
Water
Atrial Natriuretic Factor
Aldosterone
Hematocrit
Renin
Purification

Keywords

  • Antidiuresis
  • Atrial natriuretic peptide
  • AVP
  • Brattleboro rat

ASJC Scopus subject areas

  • Biochemistry
  • Clinical Biochemistry
  • Endocrinology
  • Physiology
  • Cellular and Molecular Neuroscience
  • Neuroscience(all)

Cite this

Watson, J. D., Jennings, D. B., Sarda, I. R., Pang, S. C., Lawson, B., Wigle, D. A., & Flynn, T. G. (1995). The antidiuretic effect of pneumadin requires a functional arginine vasopressin system. Regulatory Peptides, 57(2), 105-114. https://doi.org/10.1016/0167-0115(95)00024-6

The antidiuretic effect of pneumadin requires a functional arginine vasopressin system. / Watson, John D.; Jennings, Donald B.; Sarda, Inder R.; Pang, Stephen C.; Lawson, Barbara; Wigle, Dennis A; Flynn, T. Geoffrey.

In: Regulatory Peptides, Vol. 57, No. 2, 30.05.1995, p. 105-114.

Research output: Contribution to journalArticle

Watson, JD, Jennings, DB, Sarda, IR, Pang, SC, Lawson, B, Wigle, DA & Flynn, TG 1995, 'The antidiuretic effect of pneumadin requires a functional arginine vasopressin system', Regulatory Peptides, vol. 57, no. 2, pp. 105-114. https://doi.org/10.1016/0167-0115(95)00024-6
Watson, John D. ; Jennings, Donald B. ; Sarda, Inder R. ; Pang, Stephen C. ; Lawson, Barbara ; Wigle, Dennis A ; Flynn, T. Geoffrey. / The antidiuretic effect of pneumadin requires a functional arginine vasopressin system. In: Regulatory Peptides. 1995 ; Vol. 57, No. 2. pp. 105-114.
@article{2012998984a14a5d994b8ad7c2974bf5,
title = "The antidiuretic effect of pneumadin requires a functional arginine vasopressin system",
abstract = "Pneumadin is an antidiuretic decapeptide, recently isolated from rat and human lung. Bolus intravenous injection of 5 nmol of pneumadin into water-loaded rats caused a rapid and significant antidiuresis and a reduction in Na+ and Cl- excretion. Pneumadin administration did not alter mean arterial pressure, right atrial pressure, heart rate or haematocrit. Bolus intravenous injection of 20 nmol of pneumadin into non-water-loaded rats caused a significant increase in arginine vasopressin (AVP) within 10 min. Pneumadin administration also increased circulating atrial natriuretic peptide (ANP) but did not alter aldosterone or plasma renin activity levels. Injection of pneumadin into water-loaded Brattleboro rats, which genetically lack circulating AVP, did not change urine flow, confirming that the pneumadin induced antidiuresis is AVP dependent. Radioactive pneumadin was cleared from the circulation with a t 1 2β of 480.3 s. Radioactive pneumadin, isolated from plasma, eluted at an altered position on reverse phase HPLC, which indicated that the peptide was modified in vivo. This modification was also observed when synthetic pneumadin was incubated in rat plasma in vitro. Purification and sequencing of the modified synthetic peptide indicated that the modification is not a proteolytic cleavage. These results indicate that pneumadin injected into the rat caused an antidiuresis by altering circulating AVP levels.",
keywords = "Antidiuresis, Atrial natriuretic peptide, AVP, Brattleboro rat",
author = "Watson, {John D.} and Jennings, {Donald B.} and Sarda, {Inder R.} and Pang, {Stephen C.} and Barbara Lawson and Wigle, {Dennis A} and Flynn, {T. Geoffrey}",
year = "1995",
month = "5",
day = "30",
doi = "10.1016/0167-0115(95)00024-6",
language = "English (US)",
volume = "57",
pages = "105--114",
journal = "Regulatory Peptides",
issn = "0167-0115",
publisher = "Elsevier",
number = "2",

}

TY - JOUR

T1 - The antidiuretic effect of pneumadin requires a functional arginine vasopressin system

AU - Watson, John D.

AU - Jennings, Donald B.

AU - Sarda, Inder R.

AU - Pang, Stephen C.

AU - Lawson, Barbara

AU - Wigle, Dennis A

AU - Flynn, T. Geoffrey

PY - 1995/5/30

Y1 - 1995/5/30

N2 - Pneumadin is an antidiuretic decapeptide, recently isolated from rat and human lung. Bolus intravenous injection of 5 nmol of pneumadin into water-loaded rats caused a rapid and significant antidiuresis and a reduction in Na+ and Cl- excretion. Pneumadin administration did not alter mean arterial pressure, right atrial pressure, heart rate or haematocrit. Bolus intravenous injection of 20 nmol of pneumadin into non-water-loaded rats caused a significant increase in arginine vasopressin (AVP) within 10 min. Pneumadin administration also increased circulating atrial natriuretic peptide (ANP) but did not alter aldosterone or plasma renin activity levels. Injection of pneumadin into water-loaded Brattleboro rats, which genetically lack circulating AVP, did not change urine flow, confirming that the pneumadin induced antidiuresis is AVP dependent. Radioactive pneumadin was cleared from the circulation with a t 1 2β of 480.3 s. Radioactive pneumadin, isolated from plasma, eluted at an altered position on reverse phase HPLC, which indicated that the peptide was modified in vivo. This modification was also observed when synthetic pneumadin was incubated in rat plasma in vitro. Purification and sequencing of the modified synthetic peptide indicated that the modification is not a proteolytic cleavage. These results indicate that pneumadin injected into the rat caused an antidiuresis by altering circulating AVP levels.

AB - Pneumadin is an antidiuretic decapeptide, recently isolated from rat and human lung. Bolus intravenous injection of 5 nmol of pneumadin into water-loaded rats caused a rapid and significant antidiuresis and a reduction in Na+ and Cl- excretion. Pneumadin administration did not alter mean arterial pressure, right atrial pressure, heart rate or haematocrit. Bolus intravenous injection of 20 nmol of pneumadin into non-water-loaded rats caused a significant increase in arginine vasopressin (AVP) within 10 min. Pneumadin administration also increased circulating atrial natriuretic peptide (ANP) but did not alter aldosterone or plasma renin activity levels. Injection of pneumadin into water-loaded Brattleboro rats, which genetically lack circulating AVP, did not change urine flow, confirming that the pneumadin induced antidiuresis is AVP dependent. Radioactive pneumadin was cleared from the circulation with a t 1 2β of 480.3 s. Radioactive pneumadin, isolated from plasma, eluted at an altered position on reverse phase HPLC, which indicated that the peptide was modified in vivo. This modification was also observed when synthetic pneumadin was incubated in rat plasma in vitro. Purification and sequencing of the modified synthetic peptide indicated that the modification is not a proteolytic cleavage. These results indicate that pneumadin injected into the rat caused an antidiuresis by altering circulating AVP levels.

KW - Antidiuresis

KW - Atrial natriuretic peptide

KW - AVP

KW - Brattleboro rat

UR - http://www.scopus.com/inward/record.url?scp=0029003774&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029003774&partnerID=8YFLogxK

U2 - 10.1016/0167-0115(95)00024-6

DO - 10.1016/0167-0115(95)00024-6

M3 - Article

C2 - 7659786

AN - SCOPUS:0029003774

VL - 57

SP - 105

EP - 114

JO - Regulatory Peptides

JF - Regulatory Peptides

SN - 0167-0115

IS - 2

ER -